Page URL:

Podcast: Breast Cancer Risk - Facts, Fictions and the Future

28 July 2014
Appeared in BioNews 764

Will the media be forever obsessed with cancer risk? How can we separate fact from fiction in the miles of accumulated column inches amassed by cancer stories every year?

Breast cancer was a neglected disease for so long, and it may still be for half the population; why don't we hear more about breast cancer in men? How prevalent is it?

Finally, what does the future of cancer care look like? How much of the hope for better-targeted treatments launched by the genomic revolution is legitimate and how much is hot air? Will the burgeoning discipline of epigenetics play a role?

These diverse questions were inspired by audience comments from the first three events of the Progress Educational Trust's (PET) Wellcome Trust-supported series 'Breast Cancer: Chances, Choices and Genetics'. You can hear them answered by the four panellists from the final event, 'Breast Cancer Risk: Facts, Fictions and the Future', in this podcast.

Listen to the podcast using the player below, or alternatively download it by clicking here (.mp3 16.2MB).

00:00 James Brooks: Introduction
01:50 Dr James Flanagan: Epigenetics and breast cancer
08:30 Eluned Hughes: Facts and fictions in the media, and breast cancer in men
13:00 Professor Gareth Evans: The future of breast cancer screening and therapy
17:25 Fay Schopen: The media and cancer scare stories

Have your say about breast cancer and genetic testing, by taking a minute to complete the Breast Cancer Poll on BioNews here.

16 March 2015 - by Dr Meghna Kataria 
A new study has uncovered fifteen novel 'hotspots' in the human genome that increase a woman's risk of developing breast cancer - bringing the total count of known genetic risk factors to 94...
7 July 2014 - by Dr Nicola Davis 
The Progress Educational Trust's enlightening series of events on breast cancer came to a close on Thursday with 'Breast cancer risk: Facts, fiction and the future'....
30 June 2014 - by James Brooks 
Does the pharmaceutical and biotech industry's profit motive actually pervert rather than inspire innovation and the hunt for new therapies? Is the patent system well suited to a new life sciences landscape including stem cell and gene therapies?...
2 June 2014 - by James Brooks 
Is the benefit attributed to widespread breast cancer screening programmes supported by the evidence? What to make of the phenomenon of overdiagnosis, where patients are treated for cancers that would not have spread or been problematic in their lifetime?...
28 April 2014 - by James Brooks 
Did Angelina Jolie's famous editorial in the New York Times a year ago inspire an overemphasis on genetic risk in breast cancer? Or has it saved lives by bringing the issue out into the open?...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.